❭ Research by medical division ❭ Laboratory Medicine ❭ Dept. of Microbiology ❭ Genome and Epigenome Regulation in Embryo Development, Ageing and Disease [Dahl] ❭ Funding agencies ❭

Our research is funded by:

The Research Council of Norway

  • FRIPRO
  • BEDRE BEHANDLING

The Norwegian Cancer Society

The South-Eastern Norway Regional Health Authority

UiO:LifeScience
(http://www.uio.no/english/research/strategic-research-areas/life-science/)

Anders Jahres fond til vitenskapens fremme (MEDISIN)

 

 
Scroll to top

Home Dept. of Microbiology Genome and Epigenome Regulation in Embryo Development, Ageing and Disease [Dahl]

  • Group members
  • Projects
  • Publications
  • Available positions
  • Funding agencies
  • Collaborations
  • News

Recent publications

Skuland T, Fosslie M, Khodeer S, Alemu EA, Johansen JV, Indahl M, Castroviejo BC, Li Y, Lerdrup M, Dahl JA, Fedorcsak PZ, Greggains GD (2025)
Broad H3K4me3 domains support oocyte genome silencing and maturation but are dispensable for repression in early embryos
Development, 152 (21)
DOI 10.1242/dev.204638, PubMed 41143332

Li Y, Wang Y, Cengiz A, Jin KX, Castroviejo BC, Lin X, Indahl M, Zuo R, Skuland T, Fosslie M, Biba M, Wu X, Fedorcsak P, Bjørås M, Filipczyk A, Dahl JA, Greggains GD, Au KF, Klungland A (2025)
The RNA m6A landscape during human oocyte-to-embryo transition
EMBO J, 44 (14), 4150-4180
DOI 10.1038/s44318-025-00474-5, PubMed 40467862

Ellingjord-Dale M, Nygaard AB, Støer NC, Bø R, Landrø NI, Brunvoll SH, Istre M, Kalleberg KT, Dahl JA, Geng L, Tsilidis K, Riboli E, Ursin G, Søraas A (2024)
Temporal trajectories of long-COVID symptoms in adults with 22 months follow-up in a prospective cohort study in Norway
Int J Infect Dis, 149, 107263
DOI 10.1016/j.ijid.2024.107263, PubMed 39419167

More

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)